Randomized Phase III Study of Temozolomide Versus Dacarbazine in the Treatment of Patients With Advanced Metastatic Malignant Melanoma

Middleton et al. (Sat,) studied this question.

www.synapsesocial.com/papers/699ec393713733805dde645b — DOI: https://doi.org/10.1200/jco.2000.18.1.158

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Phase I study of temozolomide in paediatric patients with advanced cancer· 1998 · 139 citations
2. The role of interferon alfa in the treatment of metastatic melanoma.· 1997 · 57 citations
3. Chemosensitivity to triazene compounds and O6-alkylguanine-DNA alkyltransferase levels: Studies with blasts of leukaemic patients· 1995 · 54 citations
4. Antitumour imidazotetrazines—XV· 1987 · 119 citations
5. Melanoma: epidemiology, pathogenesis, and new modes of treatment.· 1996 · 23 citations